Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses
- Thyroidology Unit, Department of Nuclear Medicine, GATA Haydarpasa, Istanbul, Turkey
- 1Department of Nuclear Medicine, Faculty of Medicine, Ege University, Izmir, Turkey
- 2Department of Nuclear Medicine, Sifa Hospital, Izmir, Turkey
- (Requests for offprints should be addressed to O Turker; Email: otturker{at}yahoo.com)
-
Figure 2
Dose-response curves of subgroups. Note the concordance in decrement rates in groups S2, S22 and S212, who received 200 mg l-selemethionine/day, and the decreased response in group S222. Rising serum concentrations of TPOAb in group S21 clearly confirms the ineffectiveness of 100 mg l-selemethionine/day.
- Society for Endocrinology